The stock of Black Diamond Therapeutics Inc (NASDAQ:BDTX) last traded at $2.57, up 4.05% from the previous session.
BDTX stock price is now -22.97% away from the 50-day moving average and -46.70% away from the 200-day moving average. The market capitalization of the company currently stands at $145.43M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $20, Raymond James recently initiated with Outperform rating for Black Diamond Therapeutics Inc (NASDAQ: BDTX). , while ‘Stifel’ rates the stock as ‘Buy’
In other news, Versant Venture Capital VI, L., 10% Owner sold 221,600 shares of the company’s stock on Aug 28 ’24. The stock was sold for $1,400,556 at an average price of $6.32. Upon completion of the transaction, the 10% Owner now directly owns 3,726,341 shares in the company, valued at $9.58 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 31 ’24, Former Employer David Epstein bought 50,000 shares of the business’s stock. A total of $310,000 was incurred on buying the stock at an average price of $6.20. A total of 24.20% of the company’s stock is owned by insiders.
During the past 12 months, Black Diamond Therapeutics Inc has had a low of $2.15 and a high of $7.66. As of last week, the company has a debt-to-equity ratio of 0.24, a current ratio of 5.55, and a quick ratio of 5.55. The fifty day moving average price for BDTX is $3.3796 and a two-hundred day moving average price translates $4.82935 for the stock.
The latest earnings results from Black Diamond Therapeutics Inc (NASDAQ: BDTX) was released for 2024-09-30.
